Liver, biliary & pancreatic cancer
12 articles shown
When Your Local Hospital and a Major City Hospital Are 'Affiliated' — What That Partnership Actually Does, and Whether You Can Split Chemotherapy and Surgery Between Them
An explanation of what hospital affiliation agreements do and do not guarantee, why referral letters and imaging and pathology materials matter more in practice, and why one team must own the overall plan and assessment schedule if chemotherapy and surgery are split between institutions.
When Someone With a Struggling Liver Suddenly Becomes Confused or Very Sleepy — Understanding Hepatic Encephalopathy and Why Laxatives Help
Hepatic encephalopathy happens when a weakened liver can no longer clear toxins like ammonia, clouding the mind. This explains its early signs, common triggers, and why enemas and laxatives such as lactulose are used to treat it.
When You're Asked to Decide About Tube Feeding and Suctioning at the End of Life — Understanding When Artificial Nutrition, Hydration, and Suction Help, and When They Burden
When families are asked to decide about tube feeding, suctioning, and opioid pain medicine at the end of life, this article helps them understand, in broad strokes, when each measure adds comfort and when it adds burden.
When a Loved One Decides to Stop Chemotherapy and 'Only Get Other Treatments' — Why Ending Active Treatment Isn't the End of Care, and Understanding Supportive Care and Uncertain Prognosis
Choosing to stop chemotherapy is a personal decision, common in advanced cancer. This article explains that ending active treatment does not end care: palliative and supportive care continue to manage pain and symptoms, and visiting the hospital for pain relief alone is possible. It also notes that prognosis is a prediction rather than a fixed future, and that complementary therapies should be discussed with the medical team.
Does a Sudden Spike in a Tumor Marker Mean the Drug Has Stopped Working? Why One Number Is Not Enough, and How Imaging Confirms It
A sudden rise in a tumor marker during chemotherapy often triggers fear of resistance, but markers are only reference signals and one value cannot confirm that a drug has stopped working. This piece explains what drug resistance means, why marker levels fluctuate, and how CT or MRI imaging is used to assess treatment response.
When Flushing a Biliary Drain (PTBD) Hurts and the Belly Swells — Why the Tube Is Irrigated, and Telling Wait-and-Watch Signs From Report-Now Signs
An informational guide to why flushing a percutaneous biliary drain (PTBD) can cause pain or bloating, and how to tell self-limiting sensations from warning signs — such as fever or severe pain — that call for prompt medical attention.
When Breathing Grows Shallow, Urine Decreases, and the Skin Mottles: Understanding the Natural Bodily Changes Near the End of Life and How to Stay Present
An explanation of the natural physical changes—circulation, urine, breathing, and awareness—that appear near the end of life, and how families can offer comfort and stay connected while relying on the care team.
When Inflammation Markers Are Normal but the Fever Won't Break — Understanding Tumor Fever and the Many Causes of Fever in Cancer Care
Explains why a fever can persist even when inflammation markers such as CRP and procalcitonin are low during cancer care. Covers non-infectious causes including tumor fever, drug fever, dehydration, and cholangitis, and how a fever diary and warning signs guide when to call the hospital.
When Surgery Couldn't Remove It All and Chemotherapy Begins — Understanding 'Residual Disease' and Post-Surgery Treatment in Bile Duct Cancer
A plain-language guide for families facing chemotherapy after bile duct cancer (cholangiocarcinoma) surgery that left residual disease. It explains what R1 and R2 resection mean, the difference between adjuvant and palliative chemotherapy, what to expect at a first chemo admission, and why new symptoms should be reported to the care team.
When a Pancreatic Tumor Wraps Around Major Blood Vessels — Understanding Resectability and 'Conversion Surgery' After Chemotherapy
When pancreatic cancer wraps around major blood vessels and immediate surgery is not possible, doctors grade resectability (resectable, borderline, locally advanced). This piece explains conversion surgery after neoadjuvant chemotherapy and why teams may advise a few more cycles before operating.
When Your Tumor Marker (CA19-9) Drops After the First Round of Chemo — Reading the Number Calmly Before You Celebrate or Worry
An explanation of what the CA19-9 tumor marker means in pancreatic and biliary cancers, why the trend matters more than a single value, that it can rise or fall for non-cancer reasons, and why it must be read alongside imaging and symptoms.
When Gallbladder Cancer Blocks the Bile Duct: Understanding Obstructive Jaundice and Biliary Drainage
How a blocked bile duct in gallbladder cancer causes obstructive jaundice, how biliary drainage with stents or PTBD restores bile flow, why the duodenum may also need a stent, warning signs to watch with a drain, and how to prepare for a second opinion.